467 related articles for article (PubMed ID: 25874535)
1. PRMT1 promotes glucose toxicity-induced β cell dysfunction by regulating the nucleo-cytoplasmic trafficking of PDX-1 in a FOXO1-dependent manner in INS-1 cells.
Lv L; Chen H; Sun J; Lu D; Chen C; Liu D
Endocrine; 2015 Aug; 49(3):669-82. PubMed ID: 25874535
[TBL] [Abstract][Full Text] [Related]
2. Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun N-terminal kinase and involved in prostaglandin E2-induced pancreatic beta-cell dysfunction.
Meng Z; Lv J; Luo Y; Lin Y; Zhu Y; Nie J; Yang T; Sun Y; Han X
Endocrinology; 2009 Dec; 150(12):5284-93. PubMed ID: 19837872
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism.
Cochran BJ; Bisoendial RJ; Hou L; Glaros EN; Rossy J; Thomas SR; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2261-7. PubMed ID: 25147338
[TBL] [Abstract][Full Text] [Related]
4. Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner.
Choi D; Oh KJ; Han HS; Yoon YS; Jung CY; Kim ST; Koo SH
Hepatology; 2012 Oct; 56(4):1546-56. PubMed ID: 22532369
[TBL] [Abstract][Full Text] [Related]
5. Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6).
Meur G; Qian Q; da Silva Xavier G; Pullen TJ; Tsuboi T; McKinnon C; Fletcher L; Tavaré JM; Hughes S; Johnson P; Rutter GA
J Biol Chem; 2011 Apr; 286(15):13647-56. PubMed ID: 21335550
[TBL] [Abstract][Full Text] [Related]
6. PRMT1 promotes hyperglycemia in a FoxO1-dependent manner, affecting glucose metabolism, during hypobaric hypoxia exposure, in rat model.
Bayen S; Saini S; Gaur P; Duraisamy AJ; Kumar Sharma A; Pal K; Vats P; Singh SB
Endocrine; 2018 Jan; 59(1):151-163. PubMed ID: 29128891
[TBL] [Abstract][Full Text] [Related]
7. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.
Yamagata K; Daitoku H; Takahashi Y; Namiki K; Hisatake K; Kako K; Mukai H; Kasuya Y; Fukamizu A
Mol Cell; 2008 Oct; 32(2):221-31. PubMed ID: 18951090
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end-products affect transcription factors regulating insulin gene expression.
Puddu A; Storace D; Odetti P; Viviani GL
Biochem Biophys Res Commun; 2010 Apr; 395(1):122-5. PubMed ID: 20353756
[TBL] [Abstract][Full Text] [Related]
9. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models.
Chen F; Sha M; Wang Y; Wu T; Shan W; Liu J; Zhou W; Zhu Y; Sun Y; Shi Y; Bleich D; Han X
Diabetologia; 2016 Feb; 59(2):316-24. PubMed ID: 26564177
[TBL] [Abstract][Full Text] [Related]
11. Dynamic regulation of PDX-1 and FoxO1 expression by FoxA2 in dexamethasone-induced pancreatic β-cells dysfunction.
Chen F; Zhu Y; Tang X; Sun Y; Jia W; Sun Y; Han X
Endocrinology; 2011 May; 152(5):1779-88. PubMed ID: 21385937
[TBL] [Abstract][Full Text] [Related]
12. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation.
Kawamori D; Kaneto H; Nakatani Y; Matsuoka TA; Matsuhisa M; Hori M; Yamasaki Y
J Biol Chem; 2006 Jan; 281(2):1091-8. PubMed ID: 16282329
[TBL] [Abstract][Full Text] [Related]
13. Impaired PRMT1 activity in the liver and pancreas of type 2 diabetic Goto-Kakizaki rats.
Iwasaki H
Life Sci; 2009 Jul; 85(3-4):161-6. PubMed ID: 19467247
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells.
Wang H; Iezzi M; Theander S; Antinozzi PA; Gauthier BR; Halban PA; Wollheim CB
Diabetologia; 2005 Apr; 48(4):720-31. PubMed ID: 15756539
[TBL] [Abstract][Full Text] [Related]
15. Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas.
Al-Masri M; Krishnamurthy M; Li J; Fellows GF; Dong HH; Goodyer CG; Wang R
Diabetologia; 2010 Apr; 53(4):699-711. PubMed ID: 20033803
[TBL] [Abstract][Full Text] [Related]
16. Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell.
Martinez SC; Cras-Méneur C; Bernal-Mizrachi E; Permutt MA
Diabetes; 2006 Jun; 55(6):1581-91. PubMed ID: 16731820
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-alpha regulates the expression of pancreatic/duodenal homeobox-1 in rat insulinoma (INS-1) cells and ameliorates glucose-induced insulin secretion impaired by palmitate.
Sun Y; Zhang L; Gu HF; Han W; Ren M; Wang F; Gong B; Wang L; Guo H; Xin W; Zhao J; Gao L
Endocrinology; 2008 Feb; 149(2):662-71. PubMed ID: 17991720
[TBL] [Abstract][Full Text] [Related]
18. Chronic leucine exposure results in reduced but reversible glucose-stimulated insulin secretion in INS-1 cells.
Zhang X; Han W; Jiang X; Li M; Gao L; Zhao JJ
Mol Med Rep; 2014 Jun; 9(6):2554-8. PubMed ID: 24715028
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic-β-cell survival and proliferation are promoted by protein kinase G type Iα and downstream regulation of AKT/FOXO1.
Wong JC; Vo V; Gorjala P; Fiscus RR
Diab Vasc Dis Res; 2017 Sep; 14(5):434-449. PubMed ID: 28631500
[TBL] [Abstract][Full Text] [Related]
20. FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.
Zhang T; Kim DH; Xiao X; Lee S; Gong Z; Muzumdar R; Calabuig-Navarro V; Yamauchi J; Harashima H; Wang R; Bottino R; Alvarez-Perez JC; Garcia-Ocaña A; Gittes G; Dong HH
Endocrinology; 2016 Mar; 157(3):1055-70. PubMed ID: 26727107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
